InflaRx NV (IFRX)
2.09
+0.04
(+1.95%)
USD |
NASDAQ |
Sep 11, 16:00
2.08
-0.01
(-0.48%)
After-Hours: 20:00
InflaRx Price : 2.09 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 2.07 | 2.11 | 2.04 | 2.09 | 334148.0 |
| Sep 10, 2026 | 2.05 | 2.07 | 1.98 | 2.05 | 613475.0 |
| Sep 09, 2026 | 2.15 | 2.15 | 2.05 | 2.09 | 759751.0 |
| Sep 08, 2026 | 2.19 | 2.26 | 2.11 | 2.17 | 408904.0 |
| Sep 04, 2026 | 2.21 | 2.377 | 2.16 | 2.22 | 393943.0 |
| Sep 03, 2026 | 2.30 | 2.370 | 2.18 | 2.23 | 666375.0 |
| Sep 02, 2026 | 2.16 | 2.34 | 2.133 | 2.29 | 572037.0 |
| Sep 01, 2026 | 2.12 | 2.27 | 2.09 | 2.16 | 475081.0 |
| Aug 31, 2026 | 2.21 | 2.23 | 2.09 | 2.13 | 447811.0 |
| Aug 28, 2026 | 2.28 | 2.37 | 2.21 | 2.23 | 610420.0 |
| Aug 27, 2026 | 2.40 | 2.435 | 2.245 | 2.27 | 1.406M |
| Aug 26, 2026 | 2.45 | 2.50 | 2.33 | 2.42 | 1.715M |
| Aug 25, 2026 | 2.06 | 2.46 | 2.01 | 2.46 | 3.894M |
| Aug 24, 2026 | 2.10 | 2.11 | 2.03 | 2.05 | 337021.0 |
| Aug 21, 2026 | 2.03 | 2.12 | 2.025 | 2.10 | 419898.0 |
| Aug 20, 2026 | 2.12 | 2.15 | 2.005 | 2.02 | 587737.0 |
| Aug 19, 2026 | 2.18 | 2.22 | 2.09 | 2.12 | 958323.0 |
| Aug 18, 2026 | 2.05 | 2.18 | 2.035 | 2.18 | 556583.0 |
| Aug 17, 2026 | 2.04 | 2.095 | 2.03 | 2.07 | 564831.0 |
| Aug 14, 2026 | 2.01 | 2.05 | 1.92 | 2.04 | 1.468M |
| Aug 13, 2026 | 2.02 | 2.055 | 1.965 | 2.01 | 1.899M |
| Aug 12, 2026 | 1.99 | 2.06 | 1.93 | 2.01 | 1.570M |
| Aug 11, 2026 | 1.99 | 2.02 | 1.92 | 2.00 | 491391.0 |
| Aug 10, 2026 | 1.86 | 1.97 | 1.81 | 1.96 | 900604.0 |
| Aug 07, 2026 | 1.81 | 1.905 | 1.78 | 1.84 | 1.167M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| MediGene AG | 0.10 |
| BioNTech SE | 96.73 |
| Immatics NV | 8.79 |
| Beam Therapeutics, Inc. | 23.99 |
| Kymera Therapeutics, Inc. | 114.96 |
Price Related Metrics
| PS Ratio | 2345.49 |
| Price to Book Value | 1.843 |
| Earnings Yield | -31.02% |
| Market Cap | 308.00M |